NICE Decision On Arthritis Opens Door For Biosimilars

UK Recommends Treating Moderate Rheumatoid Arthritis With Three Biologic Molecules

 
• By David Wallace
Open Door Light
The NICE decision opens the door for biosimilars to treat more UK patients • Source: Alamy

More from Biosimilars

More from Products